Nuveen Asset Management, LLC Spring Works Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 297,899 shares of SWTX stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

297,899

Previous 375,664 20.7%

Holding current value

$11.6 Million

Previous $14.2 Million 32.56%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $2.49 Million - $3.33 Million	-77,765 Reduced 20.7%	297,899 $9.54 Million
Q2 2024 Aug 09, 2024	BUY	$36.06 - $47.62 $6.95 Million - $9.18 Million	192,853 Added 105.49%	375,664 $14.2 Million
Q1 2024 May 13, 2024	SELL	$36.5 - $52.5 $48,727 - $70,087	-1,335 Reduced 0.72%	182,811 $9 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $662,009 - $1.3 Million	34,953 Added 23.43%	184,146 $6.72 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $49,708 - $67,467	2,150 Added 1.46%	149,193 $3.45 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $1.4 Million - $1.98 Million	60,573 Added 70.05%	147,043 $3.86 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $206,801 - $282,002	-8,282 Reduced 8.74%	86,470 $2.23 Million
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $346,897 - $458,486	-15,964 Reduced 14.42%	94,752 $2.47 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $29,112 - $47,909	-1,208 Reduced 1.08%	110,716 $3.16 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $254,671 - $833,230	13,871 Added 14.15%	111,924 $2.76 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $570,843 - $763,067	-11,657 Reduced 10.63%	98,053 $5.88 Million
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $492,118 - $700,230	-9,233 Reduced 7.76%	109,710 $7.34 Million
Q3 2021 Nov 12, 2021	SELL	$62.66 - $88.26 $2.73 Million - $3.85 Million	-43,578 Reduced 26.81%	118,943 $8.9 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $4.69 Million - $5.95 Million	69,521 Added 74.75%	162,521 $13.4 Million
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $750,863 - $1.08 Million	-11,534 Reduced 11.03%	93,000 $6.84 Million
Q4 2020 May 17, 2021	SELL	$48.36 - $77.92 $595,505 - $959,506	-12,314 Reduced 10.54%	104,534 $7.58 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $1.45 Million - $2.33 Million	29,949 Added 34.46%	116,848 $8.47 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $6,360 - $9,150	-176 Reduced 0.2%	86,899 $4.14 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $1.02 Million - $2.15 Million	44,333 Added 103.72%	87,075 $3.66 Million
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $112,460 - $226,737	5,502 Added 14.77%	42,742 $1.15 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $660,637 - $1.47 Million	37,240 New	37,240 $1.43 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Spring Works Therapeutics, Inc. Transaction History